99% Savings - Buy Just @1 Rs X
Atropine + Diphenoxylate + Furazolidone is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Atropine + Diphenoxylate + Furazolidone is used -
Severe
Moderate
Mild
Common
Is the use of Atropine + Diphenoxylate + Furazolidone safe for pregnant women?
Side effects of Atropine + Diphenoxylate + Furazolidone during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Atropine + Diphenoxylate + Furazolidone safe during breastfeeding?
Atropine + Diphenoxylate + Furazolidone should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Atropine + Diphenoxylate + Furazolidone on the Kidneys?
Atropine + Diphenoxylate + Furazolidone can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Atropine + Diphenoxylate + Furazolidone on the Liver?
There may be an adverse effect on the liver after taking Atropine + Diphenoxylate + Furazolidone. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Atropine + Diphenoxylate + Furazolidone on the Heart?
In the absence of any scientific study on the side effects of Atropine + Diphenoxylate + Furazolidone on the heart, information on safety of Atropine + Diphenoxylate + Furazolidone for the heart is unavailable.
Atropine + Diphenoxylate + Furazolidone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Atropine + Diphenoxylate + Furazolidone unless your doctor advises you to do so -
Is this Atropine + Diphenoxylate + Furazolidone habit forming or addictive?
No, you will not get addicted to Atropine + Diphenoxylate + Furazolidone.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Atropine + Diphenoxylate + Furazolidone can make you feel drowsy.
Is it safe?
Atropine + Diphenoxylate + Furazolidone is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Atropine + Diphenoxylate + Furazolidone for mental disorders.
Interaction between Food and Atropine + Diphenoxylate + Furazolidone
Taking Atropine + Diphenoxylate + Furazolidone with food does not cause any problems.
Interaction between Alcohol and Atropine + Diphenoxylate + Furazolidone
Consult your doctor before consuming alcohol while taking Atropine + Diphenoxylate + Furazolidone as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atropine
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 113-115
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 686
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lomotil® Cv (diphenoxylate hydrochloride and atropine sulfate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lofenoxal® (diphenoxylate hydrochloride and atropine sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 844